Zhou Y - Search Results

1

Identification of mRNA binding proteins that regulate the stability of LDL receptor mRNA through AU-rich elements.

Li H, Chen W, Zhou Y, Abidi P, Sharpe O, Robinson WH, Kraemer FB, Liu J. Li H, et al. Among authors: zhou y. J Lipid Res. 2009 May;50(5):820-31. doi: 10.1194/jlr.M800375-JLR200. Epub 2009 Jan 13. J Lipid Res. 2009. PMID: 19141871 Free PMC article.

2

Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine.

Abidi P, Zhou Y, Jiang JD, Liu J. Abidi P, et al. Among authors: zhou y. Arterioscler Thromb Vasc Biol. 2005 Oct;25(10):2170-6. doi: 10.1161/01.ATV.0000181761.16341.2b. Epub 2005 Aug 11. Arterioscler Thromb Vasc Biol. 2005. PMID: 16100034

3

Analysis of polymorphisms in the 3' untranslated region of the LDL receptor gene and their effect on plasma cholesterol levels and drug response.

Chen W, Wang S, Ma Y, Zhou Y, Liu H, Strnad P, Kraemer FB, Krauss RM, Liu J. Chen W, et al. Among authors: zhou y. Int J Mol Med. 2008 Mar;21(3):345-53. Int J Mol Med. 2008. PMID: 18288382

4

Blockage of oncostatin M-induced LDL receptor gene transcription by a dominant-negative mutant of C/EBPbeta.

Zhou Y, Zhang F, Abidi P, Lin M, Thiel G, Liu J. Zhou Y, et al. Biochem J. 2006 Jul 1;397(1):101-8. doi: 10.1042/BJ20060044. Biochem J. 2006. PMID: 16563127 Free PMC article.

5

Transcriptional activation of hepatic ACSL3 and ACSL5 by oncostatin m reduces hypertriglyceridemia through enhanced beta-oxidation.

Zhou Y, Abidi P, Kim A, Chen W, Huang TT, Kraemer FB, Liu J. Zhou Y, et al. Arterioscler Thromb Vasc Biol. 2007 Oct;27(10):2198-205. doi: 10.1161/ATVBAHA.107.148429. Epub 2007 Aug 30. Arterioscler Thromb Vasc Biol. 2007. PMID: 17761945

6

Long chain acyl-CoA synthetase-3 is a molecular target for peroxisome proliferator-activated receptor delta in HepG2 hepatoma cells.

Cao A, Li H, Zhou Y, Wu M, Liu J. Cao A, et al. Among authors: zhou y. J Biol Chem. 2010 May 28;285(22):16664-74. doi: 10.1074/jbc.M110.112805. Epub 2010 Mar 22. J Biol Chem. 2010. PMID: 20308079 Free PMC article.

7

Inhibition of synuclein-gamma expression increases the sensitivity of breast cancer cells to paclitaxel treatment.

Zhou Y, Inaba S, Liu J. Zhou Y, et al. Int J Oncol. 2006 Jul;29(1):289-95. Int J Oncol. 2006. PMID: 16773211

8

Loss of epigenetic control of synuclein-gamma gene as a molecular indicator of metastasis in a wide range of human cancers.

Liu H, Liu W, Wu Y, Zhou Y, Xue R, Luo C, Wang L, Zhao W, Jiang JD, Liu J. Liu H, et al. Among authors: zhou y. Cancer Res. 2005 Sep 1;65(17):7635-43. doi: 10.1158/0008-5472.CAN-05-1089. Cancer Res. 2005. PMID: 16140929

9

Abnormal activation of the synuclein-gamma gene in hepatocellular carcinomas by epigenetic alteration.

Zhao W, Liu H, Liu W, Wu Y, Chen W, Jiang B, Zhou Y, Xue R, Luo C, Wang L, Jiang JD, Liu J. Zhao W, et al. Among authors: zhou y. Int J Oncol. 2006 May;28(5):1081-8. Int J Oncol. 2006. PMID: 16596223

10

Synuclein-gamma targeting peptide inhibitor that enhances sensitivity of breast cancer cells to antimicrotubule drugs.

Singh VK, Zhou Y, Marsh JA, Uversky VN, Forman-Kay JD, Liu J, Jia Z. Singh VK, et al. Among authors: zhou y. Cancer Res. 2007 Jan 15;67(2):626-33. doi: 10.1158/0008-5472.CAN-06-1820. Cancer Res. 2007. PMID: 17234772

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,417 results

Search Page

Filters